New RNA Interference Therapy Promises To Slice High Blood Pressure
Alynlam Pharmaceuticals recently made headlines when they announced the results of a revolutionary RNA interference therapy capable of controlling high blood pressure.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
More News: Hypertension | Pharmaceuticals